Terms: = Brain cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Prognosis
4 results:
1. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/tgfbr2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract] [Full Text] [Related]
2. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor prognosis in Glioblastoma.
Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
[TBL] [Abstract] [Full Text] [Related]
3. Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (tgfbr2) as a Novel Regulator of Glioblastoma Stem Cell Properties.
Narushima Y; Kozuka-Hata H; Koyama-Nasu R; Tsumoto K; Inoue J; Akiyama T; Oyama M
Mol Cell Proteomics; 2016 Mar; 15(3):1017-31. PubMed ID: 26670566
[TBL] [Abstract] [Full Text] [Related]
4. Distinct methylation profiles of glioma subtypes.
Uhlmann K; Rohde K; Zeller C; Szymas J; Vogel S; Marczinek K; Thiel G; Nürnberg P; Laird PW
Int J Cancer; 2003 Aug; 106(1):52-9. PubMed ID: 12794756
[TBL] [Abstract] [Full Text] [Related]
